Follow
Amaia M Erdozain
Amaia M Erdozain
Dpartment of Pharmacology, Univsersity of the Basque Country
Verified email at ehu.eus
Title
Cited by
Cited by
Year
Alcohol-related brain damage in humans
AM Erdozain, B Morentin, L Bedford, E King, D Tooth, C Brewer, D Wayne, ...
PloS one 9 (4), e93586, 2014
562014
Oxytocin as treatment for social cognition, not there yet
AM Erdozain, O Peñagarikano
Frontiers in Psychiatry 10, 483226, 2020
522020
Neurobiological alterations in alcohol addiction: a review
AM Erdozain, LF Callado
Adicciones 26 (4), 360-370, 2014
492014
Guanidine and 2-Aminoimidazoline Aromatic Derivatives as α2-Adrenoceptor Antagonists. 2. Exploring Alkyl Linkers for New Antidepressants
F Rodriguez, I Rozas, JE Ortega, AM Erdozain, JJ Meana, LF Callado
Journal of medicinal chemistry 51 (11), 3304-3312, 2008
472008
Guanidine and 2-Aminoimidazoline Aromatic Derivatives as α2-Adrenoceptor Ligands: Searching for Structure−Activity Relationships
F Rodriguez, I Rozas, JE Ortega, AM Erdozain, JJ Meana, LF Callado
Journal of medicinal chemistry 52 (3), 601-609, 2009
412009
The endocannabinoid system is altered in the post‐mortem prefrontal cortex of alcoholic subjects
AM Erdozain, M Rubio, EM Valdizan, A Pazos, JJ Meana, ...
Addiction Biology 20 (4), 773-783, 2015
392015
Neuroprotective Effects of a Structurally New Family of High Affinity Imidazoline I2 Receptor Ligands
S Abás, AM Erdozain, B Keller, S Rodríguez-Arévalo, LF Callado, ...
ACS Chemical Neuroscience 8 (4), 737-742, 2017
352017
Involvement of the endocannabinoid system in alcohol dependence: the biochemical, behavioral and genetic evidence
AM Erdozain, LF Callado
Drug and alcohol dependence 117 (2-3), 102-110, 2011
352011
The inverse agonist effect of rimonabant on G protein activation is not mediated by the cannabinoid CB1 receptor: evidence from postmortem human brain
AM Erdozain, R Diez-Alarcia, JJ Meana, LF Callado
Biochemical pharmacology 83 (2), 260-268, 2012
332012
Cartography of hevin-expressing cells in the adult brain reveals prominent expression in astrocytes and parvalbumin neurons
R Mongrédien, AM Erdozain, S Dumas, L Cutando, AN Del Moral, ...
Brain Structure and Function 224, 1219-1244, 2019
232019
Isoaspartate, carbamoyl phosphate synthase-1, and carbonic anhydrase-III as biomarkers of liver injury
WG Carter, V Vigneswara, A Newlaczyl, D Wayne, B Ahmed, ...
Biochemical and biophysical research communications 458 (3), 626-631, 2015
192015
Combining rimonabant and fentanyl in a single entity: preparation and pharmacological results
C Fernández-Fernández, LF Callado, R Girón, E Sánchez, AM Erdozain, ...
Drug design, development and therapy, 263-277, 2014
192014
The loss of α-and β-tubulin proteins are a pathological hallmark of chronic alcohol consumption and natural brain ageing
WL Labisso, AC Raulin, LL Nwidu, A Kocon, D Wayne, AM Erdozain, ...
Brain Sciences 8 (9), 175, 2018
172018
Ctr9, a protein in the transcription complex Paf1, regulates dopamine transporter activity at the plasma membrane
S De Gois, P Slama, N Pietrancosta, AM Erdozain, F Louis, ...
Journal of Biological Chemistry 290 (29), 17848-17862, 2015
172015
Novel synthesis and pharmacological evaluation as α2-adrenoceptor ligands of O-phenylisouronium salts
Á Goonan, A Kahvedžić, F Rodriguez, PS Nagle, T McCabe, I Rozas, ...
Bioorganic & medicinal chemistry 16 (17), 8210-8217, 2008
152008
Altered CB1 receptor coupling to G-proteins in the post-mortem caudate nucleus and cerebellum of alcoholic subjects
AM Erdozain, M Rubio, JJ Meana, J Fernández-Ruiz, LF Callado
Journal of Psychopharmacology 29 (11), 1137-1145, 2015
142015
Differential α2A- and α2C-adrenoceptor protein expression in presynaptic and postsynaptic density fractions of postmortem human prefrontal cortex
AM Erdozain, I Brocos-Mosquera, AM Gabilondo, JJ Meana, LF Callado
Journal of Psychopharmacology 33 (2), 244-249, 2019
122019
Structural and functional characterization of the interaction of Snapin with the dopamine transporter: differential modulation of psychostimulant actions
AM Erdozain, S De Gois, V Bernard, V Gorgievski, N Pietrancosta, ...
Neuropsychopharmacology 43 (5), 1041-1051, 2018
122018
G protein-coupled receptor heteromers as putative pharmacotherapeutic targets in autism
J DelaCuesta-Barrutia, O Peñagarikano, AM Erdozain
Frontiers in Cellular Neuroscience 14, 588662, 2020
112020
¿ Es realmente el consumo de cannabis un factor de riesgo para la esquizofrenia?
AE Fernández, C Muguruza, JJM Martínez, LFC Hernando
Norte de salud mental 8 (34), 23-33, 2009
112009
The system can't perform the operation now. Try again later.
Articles 1–20